Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30000739HIVENSG00000167286.12protein_codingCD3DNoNo915B0YIY4
P04234
TVIS30031392HIVENSG00000167286.12protein_codingCD3DNoNo915B0YIY4
P04234
TVIS44017284HTLV-1ENSG00000167286.12protein_codingCD3DNoNo915B0YIY4
P04234
TCGA Plot Options
Drug Information
GeneCD3D
DrugBank IDDB16684
Drug NameOdronextamab
Target IDBE0010202
UniProt IDP20963
Regulation Typebinder
PubMed IDs32521386; 26659273
CitationsTun AM, Ansell SM: Immunotherapy in Hodgkin and non-Hodgkin lymphoma: Innate, adaptive and targeted immunological strategies. Cancer Treat Rev. 2020 Aug;88:102042. doi: 10.1016/j.ctrv.2020.102042. Epub 2020 May 30.@@Smith EJ, Olson K, Haber LJ, Varghese B, Duramad P, Tustian AD, Oyejide A, Kirshner JR, Canova L, Menon J, Principio J, MacDonald D, Kantrowitz J, Papadopoulos N, Stahl N, Yancopoulos GD, Thurston G, Davis S: A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys. Sci Rep. 2015 Dec 11;5:17943. doi: 10.1038/srep17943.
GroupsInvestigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL